The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak …

Background and purpose Infections with coronaviruses are not always confined to the
respiratory tract and various neurological manifestations have been reported. The aim of this …

Background and purpose We systematically reviewed available evidence for reports of
neurological signs and symptoms in patients with COVID‐19 to identify cases with severe …

Abstract Introduction Coronavirus disease-19 (COVID-19) pandemic continues to grow all
over the world. Several studies have been performed, focusing on understanding the acute …

Purpose of Review Neurologic complications are increasingly recognized in the coronavirus
disease 2019 (COVID-19) pandemic. COVID-19 is caused by the novel severe acute …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases …

Introduction The past two decades have been marked by three epidemics linked to
emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological …

Objective The coronavirus disease 2019 (COVID-19) has spread worldwide since
December 2019. Neurologic symptoms have been reported as part of the clinical spectrum …

Acute and post-acute neurological symptoms, signs and diagnoses have been documented
in an increasing number of patients infected by the Severe Acute Respiratory Syndrome …

The Coronavirus disease due to SARS-CoV-2 emerged in Wuhan city, China in December
2019 and rapidly spread to more than 200 countries as a global health pandemic. There are …